
1.66 Delayed Data As of Feb 02 | ![]() Today’s Change | 1.10 Today|||52-Week Range 4.72 | +28.68% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $120.8M |
Gamida Cell Ltd. 116 Huntington Avenue Boston Massachusetts 02116 |
Abigail L. Jenkins | President, Chief Executive Officer & Director |
Michele I. Korfin | Chief Operating & Commercial Officer |
Shai Lankry | Chief Financial Officer |
Ronit Simantov | Chief Medical & Scientific Officer |
Yona Geffen | Vice President-Research & Development |